Muhammed Iraqi

4PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 26, 2022
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs.

Muhammed Iraqi, Priyanka Bolel, Rhitajit Sarkar

|May 14, 2022
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma.

Muhammed Iraqi, Avishay Edri, Yariv Greenshpan

|Feb 24, 2022
Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 Vaccination.

Walid Shalata, Daniel Levin, Janna Fridman

Pageof 1